And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still taking shape, but we plan on promenading with the official mascots, catching up on our reading, escorting Mrs. Pharmalot to a…
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter. A little-noticed policy shift by Medicare caused a seven-year delay in choosing a costly AbbVie medicine for price negotiations, a move likely to…
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter. The Trump administration has revised the terms of a pilot effort that will allow some drugmakers to offer rebates to certain hospitals and…
WASHINGTON — A man whose slain brother led one of Mexico’s most powerful and violent drug cartels pleaded guilty Friday in Washington to conspiring to traffic cocaine and methamphetamine into the U.S. Antonio Oseguera Cervantes worked for cartels with his brother Nemesio Rubén Oseguera Cervantes, the drug lord known as “El Mencho” who was killed…
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — Half a year into taking over the job, GSK CEO Luke Miels on Tuesday laid out his plans to turn the U.K. pharma giant into a more agile company with years…
Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of health care. Confidential tips can be sent on Signal at danielp.100. WASHINGTON — Last week, pharmaceutical leaders filed into a meeting room in the Eisenhower Executive…
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter. Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks to hospitals that participate in…
The Parkinson’s disease combination drug Hopledo (levodopa–carbidopa, Zambon S.p.A.) has received a positive opinion by the European Medicines Agency (EMA). Hopledo’s components, levodopa and carbidopa, are established Parkinson’s drugs that are often combined. The new formulation consists of modified-release hard capsules that contain both immediate-release granules and extended-release beads. The immediate-release granules consist of levodopa…
